Dexmethylphenidate 5 Mg Oral Capsule, Extended Release + Dexmethylphenidate 6.25 mg Tablet + Dexmethylphenidate 40 Mg Oral Capsule, Extended Release + Dexmethylphenidate 50 mg Tablet
Phase 1/2Completed 0 views this week 0 watching💤 Quiet
Interest: 22/100
22
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedAbout Dexmethylphenidate 5 Mg Oral Capsule, Extended Release + Dexmethylphenidate 6.25 mg Tablet + Dexmethylphenidate 40 Mg Oral Capsule, Extended Release + Dexmethylphenidate 50 mg Tablet
Dexmethylphenidate 5 Mg Oral Capsule, Extended Release + Dexmethylphenidate 6.25 mg Tablet + Dexmethylphenidate 40 Mg Oral Capsule, Extended Release + Dexmethylphenidate 50 mg Tablet is a phase 1/2 stage product being developed by Cingulate for ADHD. The current trial status is completed. This product is registered under clinical trial identifier NCT04138498. Target conditions include ADHD.
What happened to similar drugs?
10 of 20 similar drugs in ADHD were approved
Approved (10) Terminated (2) Active (10)
Hype Score Breakdown
Clinical
9
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04138498 | Phase 1/2 | Completed |
Competing Products
20 competing products in ADHD